All In Biotech

Drug Trial Radar · NCT06980649

Study of BHV-1300 in Graves' Disease

An Open-Label Biomarker Study of BHV-1300 in Graves' Disease

Last checked: Nov 20, 2026Latest source record: Jul 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

15

Planned (sponsor's estimate)

Start

Aug 21, 2025

Primary completion

Sep 2027

Study completion Sep 2027

Sponsor

Lead sponsor
Biohaven Therapeutics Ltd.Industry
Sponsor type
Industry
First posted
May 20, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if BHV-1300 is a safe treatment in participants with Graves' Disease and to explore its effect on disease-specific biomarkers.

Conditions

  • Graves Disease

Interventions

  • BHV-1300Drug

    BHV-1300 is delivered subcutaneously (SC)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with Serious AEs (SAEs), AEs leading to discontinuation, deathsTime frame: Baseline to Week 52
  2. Number of participants with Grade 3-4 (CTCAE/DAIDS) treatment-emergent laboratory abnormalitiesTime frame: Baseline to Week 52

Locations

18 sites in 2 countries. Site status is shown where the registry gives one.

  • Site-103

    South Gate, California · Recruiting

  • Site-100

    Miami, Florida · Recruiting

  • Site-104

    Columbus, Georgia · Recruiting

  • Site-108

    Greenville, North Carolina · Recruiting

  • Site-110

    Canton, Ohio · Recruiting

  • Site-107

    Memphis, Tennessee · Recruiting

  • Site-109

    Dallas, Texas · Recruiting

  • Site-106

    Houston, Texas · Recruiting

  • Site-101

    Houston, Texas · Recruiting

  • Site-105

    Shavano Park, Texas · Recruiting

  • Site-004

    Fitzroy, Australia · Recruiting

  • Site-011

    Herston, Australia · Recruiting

  • Site-001

    Kotara, Australia · Recruiting

  • Site-003

    Melbourne, Australia · Recruiting

  • Site-010

    Oaklands Park, Australia · Recruiting

  • Site-008

    Parkville, Australia · Recruiting

  • Site-006

    St Leonards, Australia · Recruiting

  • Site-002

    Torquay, Australia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.